secwatch.observer — SEC 8-K summary
======================================

Issuer:     ABEONA THERAPEUTICS INC. (ABEO)
CIK:        0000318306
Form:       8-K
Filed at:   2023-07-03T23:59:59+00:00
Accession:  0001493152-23-023235
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Abeona raises $25M in registered direct offering at $4.03/share to fund EB-101 launch prep
--------------------------------------------------------------------------------

- Gross proceeds ~$25M; net ~$22.9M after fees and expenses.
- Issued 3,284,407 shares and pre-funded warrants for 2,919,140 shares at $4.03 per share.
- Proceeds primarily for commercial launch preparation for gene therapy EB-101 (BLA pending).
- Offering led by Nantahala Capital Management; includes Adage Capital Partners and two other institutions.
- Closing expected on or about July 6, 2023, subject to customary conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/318306/000149315223023235/0001493152-23-023235-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/318306/000149315223023235/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-023235

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer